| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/08/2002 | EP1202755A1 Cartilage or bone matrix as a nucleic acid delivery vehicle |
| 05/08/2002 | EP1202748A2 Polycation-based bioconjugates |
| 05/08/2002 | EP1202747A1 Sustained release drug dispersion delivery device |
| 05/08/2002 | EP1202744A2 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 05/08/2002 | EP1202743A2 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 05/08/2002 | EP1202739A1 Rapid immediate release oral dosage form |
| 05/08/2002 | EP1202722A1 Uses compositions for treating or preventing sleep disturbances using very low doses of cyclobenzaprine |
| 05/08/2002 | EP1202719A1 Anesthetic composition for intravenous injection comprising propofol |
| 05/08/2002 | EP1202716A1 Rapidly dissolving dosage form and process for making same |
| 05/08/2002 | EP1202715A2 Quick-release extrudates, method for preparing the same and compositions obtained from said extrudates |
| 05/08/2002 | EP1202713A2 Artificial tear replacement solution |
| 05/08/2002 | EP1202706A1 Lysine oxidase linkage of agents to tissue |
| 05/08/2002 | EP1202703A2 Oil-based cosmetics containing water-soluble actives |
| 05/08/2002 | EP1202700A1 Oil-in-water emulsion with improved stability |
| 05/08/2002 | EP1202639A2 Methods for suppressing appetite and enhancing exercise and recovery |
| 05/08/2002 | EP0839052B1 Use of hyaluronic acid and a nsaid for the manufacture of a medicament for the treatment of mucosal diseases |
| 05/08/2002 | EP0773780B1 Controlled release aqueous emulsion |
| 05/08/2002 | EP0724618B1 Stabilisation of polyunsaturates |
| 05/08/2002 | EP0620828B1 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| 05/08/2002 | DE10152369A1 Stable, propellant-free inhalable liquid medicament for treating asthma or chronic obstructive pulmonary disease, containing tiotropium salt and antiallergic agent, antihistamine, steroid or leukotriene antagonist |
| 05/08/2002 | DE10053866A1 Biocompatible liquid formulation, containing a mixture of biopolymers, useful as a lubricant in human and veterinary medicine |
| 05/08/2002 | DE10053383A1 Verwendung von Terpenen als Enhancer der transmucosalen Resorption und Terpene enthaltende pharmazeutische Zubereitungen Use containing terpenes as an enhancer of transmucosal absorption and terpenes pharmaceutical preparations |
| 05/08/2002 | DE10053267A1 Neuartiges Verfahren zur Herstellung von mikrosphärischen Kristalliten aus linearen Polysacchariden, entsprechende mikrosphärische Kristallite und deren Verwendung Novel method for producing microspherical crystallites of linear polysaccharides, corresponding microspherical crystallites and their use |
| 05/08/2002 | CN1348483A Stable, aqueous dispersions and stable, water-dispersible dry powders of xanthophylls, and production and use of the same |
| 05/08/2002 | CN1348466A Epitopes or mimotopes derived from the c-epsilon-2-domain of IgE, antagonists thereof, and their therapeutic uses |
| 05/08/2002 | CN1348386A Prucalopride oral solution |
| 05/08/2002 | CN1348384A An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport |
| 05/08/2002 | CN1348383A Prolonged release microsphere encapsulating luteinizing hormone-releasing hormone analogues and method for preparing the same |
| 05/08/2002 | CN1348380A Herbal composition and medicament against diabetes mellitus type II manufactured thereof |
| 05/08/2002 | CN1348369A Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| 05/08/2002 | CN1348367A Percutaneous absorption preparations containing oxybutynin |
| 05/08/2002 | CN1348366A Transdermal therapeutic system with a highly effective neuroleptic agent |
| 05/08/2002 | CN1348365A Chewing gum with dental benefits including calcium in a food grade acid |
| 05/08/2002 | CN1348364A Chewable soft capsules having improved administration properties and process for producing the same |
| 05/08/2002 | CN1348361A Method for preparing coated drug particles and pharmaceutical formulations thereof |
| 05/08/2002 | CN1348360A Preparation of aqueous clear solution dosage forms with bile acids |
| 05/08/2002 | CN1348359A Composition for medicated chewing gums process for manufacturing the same and tablets so obtained |
| 05/08/2002 | CN1084209C High polymer antineoplastic guide medicine and preparation thereof |
| 05/08/2002 | CN1084188C Preparation of ciprofloxacin pharmaceutical formulation composition |
| 05/08/2002 | CN1084186C Liposome composition containing selegilin |
| 05/07/2002 | US6384259 Heat resistant, sterile dosage suitable for reconstitution with a vehicle into an injectible, particle-free product for parenteral administration |
| 05/07/2002 | US6384252 Fatty acids or derivatives; mammalian mammary glands secretion; stress, anxiety and aggression reduction |
| 05/07/2002 | US6384198 Methods for inhibiting the production of HIV-1 retrovirus using monoclonal antibodies and Fv specific for CD2 antigen |
| 05/07/2002 | US6384195 Produced by partitioning method; therapeutics |
| 05/07/2002 | US6384064 Human immunodeficiency syndrone, hepatitis virus |
| 05/07/2002 | US6384023 Silicone gel containing salicylic acid |
| 05/07/2002 | US6384020 Rapid immediate release oral dosage form |
| 05/07/2002 | US6384016 One peptide selected from glucagon, glp-1, and analogues and derivatives thereof together with a stabilizing and solubilizing amount of at least one detergent, said detergent having at least 2 positive charges, at least 2 negative |
| 05/07/2002 | US6383811 Forming a complex of polyampholyte and polyion and delivering the complex into a cell; drug delivery |
| 05/07/2002 | US6383788 Minimizing thermally induced aggregation of DNase in solution with calcium |
| 05/07/2002 | US6383516 Sustained-release microgranules containing diltiazem as active principle |
| 05/07/2002 | US6383514 Hypocholesterolemic composition comprising a phytostanol ester and a tocopherol |
| 05/07/2002 | US6383513 Compositions comprising cannabinoids |
| 05/07/2002 | US6383510 Suppository form comprising an acid-labile active compound |
| 05/07/2002 | US6383509 Continuous in vivo release of a neurotoxin over a treatment period extending from one month to five years; neurotoxin, especially botulinum toxin or clostridial neurotoxin, within a polymeric matrix |
| 05/07/2002 | US6383502 Non-stinging coating composition |
| 05/07/2002 | US6383490 Drug abuse or dependance |
| 05/07/2002 | US6383489 Inactivation of granulocytes in the treatment of established allergic responses |
| 05/07/2002 | US6383478 Polymeric encapsulation system promoting angiogenesis |
| 05/07/2002 | US6383471 Drug delivery |
| 05/07/2002 | CA2214884C Poly(hydroxy acid)/polymer conjugates for skin applications |
| 05/07/2002 | CA2205305C Stable budesonide solutions, method of preparing them and use of these solutions as enema preparations and pharmaceutical foams |
| 05/07/2002 | CA2175842C Transesterified corn oil products |
| 05/07/2002 | CA2085871C A controlled release drug dispersion delivery device |
| 05/02/2002 | WO2002034879A2 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 05/02/2002 | WO2002034816A1 Method for producing microspherical crystallites from linear polysaccharides, corresponding microspherical crystallites and the use thereof |
| 05/02/2002 | WO2002034793A2 Rheology modifying copolymer composition |
| 05/02/2002 | WO2002034763A2 Mucin comprising vehicle for the transport of biologically-active agents |
| 05/02/2002 | WO2002034741A2 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL)ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE |
| 05/02/2002 | WO2002034304A1 Self-adhesive hydratable matrix for topical therapeutic use |
| 05/02/2002 | WO2002034299A1 Inorganic low density radionuclide coated particles |
| 05/02/2002 | WO2002034298A1 Low density radionuclide-containing particulate material |
| 05/02/2002 | WO2002034295A1 Synthetic regulatory compounds |
| 05/02/2002 | WO2002034294A1 Use of terpenes as enhancers of transmucosal resorption, and pharmaceutical preparations containing terpenes |
| 05/02/2002 | WO2002034293A2 Use of citric acid as antimicrobial agent or enhancer or as anticancer agent |
| 05/02/2002 | WO2002034286A1 Methods for treating endocrine disorders |
| 05/02/2002 | WO2002034271A1 New composition and method for the treatment of dysglucaemia |
| 05/02/2002 | WO2002034267A1 Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states |
| 05/02/2002 | WO2002034259A1 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction |
| 05/02/2002 | WO2002034252A1 Drug composition comprising dipeptydyl aldehyde derivative |
| 05/02/2002 | WO2002034250A1 Fat emulsions |
| 05/02/2002 | WO2002034240A2 Delayed and sustained release formulations and method of use thereof |
| 05/02/2002 | WO2002034237A1 Active agent delivery systems and methods for protecting and administering active agents |
| 05/02/2002 | WO2002034236A2 Lipid formulations for target delivery |
| 05/02/2002 | WO2002034235A1 Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid |
| 05/02/2002 | WO2002034234A2 Methylphenidate modified release formulations |
| 05/02/2002 | WO2002034221A1 Dental care compositions |
| 05/02/2002 | WO2002034200A2 Transdermal therapeutic systems comprising photosensitive active substances |
| 05/02/2002 | WO2002034117A2 Multiple epitopes connected by a carrier |
| 05/02/2002 | WO2002011710A3 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 05/02/2002 | WO2002011564A3 Supplement for type 2 diabetes or lipodystrophy |
| 05/02/2002 | WO2002005822A3 Compositions containing therapeutically active components having enhanced solubility |
| 05/02/2002 | WO2002005746A3 The process of manufacturing pharmaceutical grade tannates |
| 05/02/2002 | WO2001095877A3 Porous celecoxib matrices and methods of manufacture thereof |
| 05/02/2002 | WO2001091803A3 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 05/02/2002 | WO2001077137A9 Albumin fusion proteins |
| 05/02/2002 | WO2001074401A3 Camptothecin complexes |
| 05/02/2002 | WO2001068708A3 Human and humanized fap-alpha-specific antibodies |
| 05/02/2002 | WO2001066772A3 Heparinase iii and uses thereof |
| 05/02/2002 | WO2001062931A3 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF |